Published in Clin Kidney J on February 01, 2012
Magnesium basics. Clin Kidney J (2012) 1.62
Magnesium in Prevention and Therapy. Nutrients (2015) 1.11
Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival. Clin Kidney J (2012) 1.00
Regulation of magnesium balance: lessons learned from human genetic disease. Clin Kidney J (2012) 0.99
Magnesium and osteoporosis: current state of knowledge and future research directions. Nutrients (2013) 0.96
Magnesium intake is inversely associated with coronary artery calcification: the Framingham Heart Study. JACC Cardiovasc Imaging (2013) 0.96
Dietary magnesium and genetic interactions in diabetes and related risk factors: a brief overview of current knowledge. Nutrients (2013) 0.82
Serum magnesium levels in patients with diabetic retinopathy. J Nat Sci Biol Med (2013) 0.81
Magnesium modulates the expression levels of calcification-associated factors to inhibit calcification in a time-dependent manner. Exp Ther Med (2015) 0.78
Increases in intravenous magnesium use among hospitalized patients: an institution cross-sectional experience. Can J Kidney Health Dis (2015) 0.75
Serum Magnesium and Vitamin D Levels as Indicators of Asthma Severity. Pulm Med (2016) 0.75
The effect of acute vs chronic magnesium supplementation on exercise and recovery on resistance exercise, blood pressure and total peripheral resistance on normotensive adults. J Int Soc Sports Nutr (2015) 0.75
Seaweeds as Preventive Agents for Cardiovascular Diseases: From Nutrients to Functional Foods. Mar Drugs (2015) 0.75
Magnesium in obstetric anesthesia and intensive care. J Anesth (2016) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA (2002) 25.68
Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet (2002) 10.48
Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet (1995) 9.50
Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) Lancet (1994) 8.63
Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol (1989) 5.73
Pre-eclampsia: more than pregnancy-induced hypertension. Lancet (1993) 4.91
Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology (2010) 4.61
Magnesium: physiology and pharmacology. Br J Anaesth (1999) 4.33
Pathophysiology of insulin resistance in human disease. Physiol Rev (1995) 3.95
A prospective study of nutritional factors and hypertension among US men. Circulation (1992) 3.51
Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) Lancet (1992) 3.40
Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy. Am J Cardiol (1995) 2.98
Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. BMJ (1991) 2.81
Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med (1999) 2.69
The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation. Eur Heart J (2000) 2.56
A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med (1995) 2.49
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation (2010) 2.49
Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Arch Intern Med (2007) 2.47
Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta (2000) 2.45
Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care (2004) 2.24
Magnesium: nature's physiologic calcium blocker. Am Heart J (1984) 2.23
Dietary calcium and magnesium, major food sources, and risk of type 2 diabetes in U.S. black women. Diabetes Care (2006) 1.98
Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation (1998) 1.94
Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol (2007) 1.90
Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care (2004) 1.86
Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med (2006) 1.72
Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol (1995) 1.67
Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2. Clin Nephrol (2005) 1.67
Decreases by magnesium of QT dispersion and ventricular arrhythmias in patients with acute myocardial infarction. Eur Heart J (1999) 1.67
Magnesium intake and risk of type 2 diabetes: a meta-analysis. J Intern Med (2007) 1.65
Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr (1992) 1.65
Magnesium basics. Clin Kidney J (2012) 1.62
Magnesium intake and incidence of metabolic syndrome among young adults. Circulation (2006) 1.57
Effect of magnesium on blood pressure. Br Med J (Clin Res Ed) (1983) 1.54
The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens (2002) 1.54
Magnesium sulfate for the treatment of eclampsia: a brief review. Stroke (2009) 1.52
Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care (2003) 1.50
Magnesium intake and the metabolic syndrome: epidemiologic evidence to date. J Cardiometab Syndr (2006) 1.48
Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J (1998) 1.46
Serum ionized magnesium levels in normal and preeclamptic gestation. Obstet Gynecol (1997) 1.45
Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care (2005) 1.42
Dietary calcium and magnesium intakes and the risk of type 2 diabetes: the Shanghai Women's Health Study. Am J Clin Nutr (2009) 1.40
Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol (2009) 1.40
A practical approach to torsade de pointes. Clin Cardiol (1997) 1.36
Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab (2004) 1.36
Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr (2007) 1.34
Low serum magnesium levels and metabolic syndrome. Acta Diabetol (2002) 1.31
Relationship of magnesium intake and other dietary factors to blood pressure: the Honolulu heart study. Am J Clin Nutr (1987) 1.30
Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Meta-analysis of magnesium in acute myocardial infarction. Circulation (1992) 1.27
Mg2+-Ca2+ interaction in contractility of vascular smooth muscle: Mg2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels. Can J Physiol Pharmacol (1987) 1.22
Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant (2011) 1.20
Low serum magnesium concentrations predict cardiovascular and all-cause mortality. Atherosclerosis (2011) 1.19
Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care (2009) 1.18
The biology of preeclampsia. Kidney Int (2009) 1.16
Magnesium supplementation for the management of essential hypertension in adults. Cochrane Database Syst Rev (2006) 1.14
Magnesium and cardiovascular system. Magnes Res (2010) 1.10
Clinical and therapeutic aspects of congenital and acquired long QT syndrome. Am J Med (2002) 1.09
Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction. Arch Intern Med (1987) 1.08
Update on the relationship between magnesium and exercise. Magnes Res (2006) 1.08
Magnesium metabolism in health and disease. Dis Mon (1988) 1.08
Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial. Diabetes Obes Metab (2011) 1.07
Serum magnesium and ischaemic heart disease: findings from a national sample of US adults. Int J Epidemiol (1999) 1.07
Is hypomagnesemia arrhythmogenic? Clin Cardiol (1992) 1.06
Effects of magnesium supplementation in hypertensive patients: assessment by office, home, and ambulatory blood pressures. Hypertension (1998) 1.06
Renal hypomagnesaemia in human diabetes mellitus: its relation to glucose homeostasis. Eur J Clin Invest (1982) 1.05
Magnesium and cardiovascular biology: an important link between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res (1995) 1.05
New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. I. Clinical aspects. Magnesium (1985) 1.04
Suppression of ventricular arrhythmias by magnesium. Am J Cardiol (1990) 1.04
Magnesium therapy for torsades de pointes. Am J Cardiol (1984) 1.03
Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival. Clin Kidney J (2012) 1.00
Regulation of magnesium balance: lessons learned from human genetic disease. Clin Kidney J (2012) 0.99
The dose-dependent reduction in blood pressure through administration of magnesium. A double blind placebo controlled cross-over study. Am J Hypertens (1993) 0.99
Lack of effect of oral magnesium on high blood pressure: a double blind study. Br Med J (Clin Res Ed) (1985) 0.98
L-type calcium channels are involved in mediating the anti-inflammatory effects of magnesium sulphate. Br J Anaesth (2010) 0.98
Magnesium in clinical medicine. Front Biosci (2004) 0.97
Intravenous magnesium sulfate prophylaxis for atrial fibrillation after coronary artery bypass surgery. J Thorac Cardiovasc Surg (2003) 0.97
Ionic basis of hypertension, insulin resistance, vascular disease, and related disorders. The mechanism of "syndrome X". Am J Hypertens (1993) 0.96
Serum and intracellular magnesium during normal pregnancy and in patients with pre-eclampsia. Br J Obstet Gynaecol (1992) 0.96
Hypomagnesaemia is associated with diabetes: Not pre-diabetes, obesity or the metabolic syndrome. Diabetes Res Clin Pract (2009) 0.95
Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxin. Am J Cardiol (1986) 0.94
Dietary magnesium intake and blood pressure: a qualitative overview of the observational studies. J Hum Hypertens (1998) 0.93
Advanced life support drugs: do they really work? Curr Opin Crit Care (2002) 0.93
Myocardial tissue concentrations of magnesium and potassium in men dying suddenly from ischemic heart disease. Am J Clin Nutr (1979) 0.92
Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension. Am J Hypertens (2009) 0.92
The physiology of pre-eclampsia. Clin Exp Pharmacol Physiol (1995) 0.92
The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects. Br J Nutr (1997) 0.91
Randomised, cross-over, placebo controlled trial of magnesium citrate in the treatment of chronic persistent leg cramps. Med Sci Monit (2002) 0.91
Magnesium and blood pressure: review of the epidemiologic and clinical trial experience. Am J Cardiol (1989) 0.91
Intracellular Mg2+, Ca2+, Na2+ and K+ in platelets and erythrocytes of essential hypertension patients: relation to blood pressure. Clin Exp Hypertens A (1992) 0.91
Magnesium for the treatment of nocturnal leg cramps: a crossover randomized trial. J Fam Pract (1999) 0.90
Evidence that prostacyclin mediates the vascular action of magnesium in humans. Hypertension (1987) 0.90
The nitric oxide pathway in pre-eclampsia: pathophysiological implications. Hum Reprod Update (1998) 0.90
Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation. Diabetes Res Clin Pract (2011) 0.90
Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial. Magnes Res (2008) 0.89
The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes. Diabetes Res Clin Pract (2004) 0.89
Serum magnesium, ambulatory blood pressure, and carotid artery alteration: the Ohasama study. Am J Hypertens (2010) 0.89